ID-1 gene downregulation by sulindac sulfide and its upregulation during tumor development in gastric cancer

International Journal of Cancer

Volumn 118, Issue 6, 2006, Pages 1356-1363

  Jang, Tae Jung ^a   Jung, Ki Hoon ^a   Choi, Eun A ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Gastric cancer; Id 1; Sulindac sulfide

Indexed keywords

ABC TRANSPORTER; ACTIVATING TRANSCRIPTION FACTOR 3; ADRENOMEDULLIN; AMPHIREGULIN; CCAAT ENHANCER BINDING PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; CRYSTALLIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME P450; CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 6; GLYCEROL KINASE; HEAT SHOCK PROTEIN 70; INHIBITOR OF DIFFERENTIATION 1; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; KI 67 ANTIGEN; LAMININ; METALLOTHIONEIN I; METHIONINE TRANSFER RNA LIGASE; NONSTEROID ANTIINFLAMMATORY AGENT; ORNITHINE DECARBOXYLASE; OXIDOREDUCTASE; PROTEIN SERINE THREONINE KINASE; STROMELYSIN 2; SULINDAC SULFIDE; THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR AP 2; URIDINE PHOSPHORYLASE;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CELL CYCLE; CELL DIFFERENTIATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ID 1 GENE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; UNINDEXED SEQUENCE; WESTERN BLOTTING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; SULINDAC; UP-REGULATION;

EID: 33644551208     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21503     Document Type: Article

References (52)

1. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations and medications: case control results frorn the Melbourne Colorectal Cancer Study. Cancer Res 1988;48:4399-404.
2. Coogan PF, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S. Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol Biomarkers Prev 2000;9:119-23.
3. Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. Br Med J 2000;320:1642-6.
4. Baek SJ, Kim KS, Nixon JB, Wilson LG, Eling TE. Cyclooxygenase inhibitors regulate the expression of a TGF-β superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 2001;59:901-8.
5. Goel A, Chang DK, Ricciardiello L, Gasche C, Boland CR. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res 2003;9:383-90.
6. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 1996;52:237-45.
7. Zhang X, Morham SG, Langenbach R, Young DA. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med 1999;190:451-9.
8. Jang TJ, Kang HJ, Kim JR, Yang CH. Nonsteroidal anti-inflammatory drug activated gene (NAC-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis. Carcinogenesis 2004;25:1853-8.
9. Bottone FG, Martinez JM, Collins JB, Afshari CA, Eling TE. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis. J Biol Chem 2003;278:25790-801.
10. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 1990;61:49-59.
11. Norton JD, Atherton GT. Coupling of cell growth control and apoptosis functions of Id proteins. Mol Cell Biol 1998;18:2371-81.
12. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 2000;113:3897-905.
13. INK4a/pRB pathway. Carcinogenesis 2003;23:721-5.
14. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Munger K. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad Sci USA 1999;96:9637-41.
15. Langlands K, Down GA, Kealey T. Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. Cancer Res 2000;60:5929-33.
16. Maruyama H, Kleeff J, Wildi S, Friess H, Buchler MW, Israel MA, Korc M. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol 1999;155:815-22.
17. Ouyang XS, Wang X, Lee DT, Tsao SW, Wong YC. Over expression of ID-1 in prostate cancer. J Urol 2002;167:2598-602.
18. Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R, Birner P. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer 2003;104:677-82.
19. Wang QI, Tsao SW, Fu S, Xue W, Meng X, Feng H, Wong YC, Wang X. Overexpression of Id-1 in gastric adenocarcinoma: implication for a novel diagnostic marker. Anticancer Res 2004;24:881-6.
20. Sehindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res 2001;61:5703-6.
21. Fong S, Itahana Y, Sumida T, Singh J, Coppe JP, Liu Y, Richards PC, Bennington JL, Lee NM, Debs RJ, Desprez PY. Id-1 as a molecular target in the therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci 2003;100:13543-8.
22. Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissel MJ, Campisi J. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol Cell Biol 1998;18:4577-88.
23. Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, Getz G, Domany E, Givol D. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 2001;20:2225-34.
24. 2-terminal kinase and promoter response element. Blood 2000;96:2140-8.
25. Fan F, Jin S, Amundson SA, Tong T, Fan W, Zhao H, Mazzacurati L, Petrik KL, Fornace AJ, Jr, Rajasekaran B, Zhan Q. ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene 2002;21:7488-96.
26. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with glioma. Clin Cancer Res 2004;10:2072-81.
27. Zeng ZU, Yang LY, Ding X, Wang W. Expression of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance. World J Surg 2004;10:3414-8.
28. Moritani NH, Kubota S, Nishida T, Kawaki H, Kondo S, Sugahara T, Takigawa M. Suppressive effect of overexpressed connective tissue growth factor on tumor cell growth in human oral squamous cell carcinoma-derived cell line. Cancer Lett 2003;192:205-14.
29. Lin BR, Chang CC, Che TF, Chen ST, Chen RT, Yang GY, Jeong YM, Liang JT, Lee PH, Chang KJ, Kuo ML. Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology 2005;128:9-23.
30. Hishikawa K, Oemar BS, Tanner EC, Nakaki T, Luscher TF, Fujii T. Connective tissue growth factor induces apoptosis in human breast cancer cell lines MGF-7. J Biol Chem. 1999;274:37461-6.
31. Hishikawa K, Nakaki T, Fujii T. Connective, tissue growth factor induces apoptosis via caspase 3 in cultured human aortic smooth muscle cells. Eur J Pharmacol 2000;392:19-22.
32. Stronach EA, Sellar GC, Blenkiron C, Rabiasz GJ, Taylor KJ, Miller EP, Massie CE, Al-Nafussi A, Smyth JF, Porteous DJ, Gabra H. Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression. Cancer Res 2003;63:8648-55.
33. Takashi M, Katsuno S, Sakata T, Ohshima S, Kato K. Different concentrations of two small stress proteins, αB-crystaliih and HSP27 in human urological tumor tissues. Urol Res 1998;26:395-9.
34. Klemenz R, Scheier B, Muller A, Steiger R, Aoyama A. αB crystallin expression in response to hormone, oncogenes and stress. Verh Dtsch Ges Pathol 1994;78:34-5.
35. Shintani Y, Higashiyama S, Ohta M, Hirabayashi H, Yamamoto S, Yoshimasu T, Matsuda H, Matsura N. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res 2004;64:4190-6.
36. Carl-McGrath S, Lendeckel U, Ebert M, Roessner A, Rocken C. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol 2005;26:17-24.
37. Dawson G, Dawson SA, Marinzi C, Dawson PE. Anti-tumor promoting effects of palmitoyl: protein thioesterase inhibitors against a human neurotumor cell line. Cancer Lett 2002;187:163-8.
38. Cho S, Dawson G. Palmitoyl protein thioesterase 1 protects against apoptosis mediated by Ras-Akt-caspase pathway in neuroblastoma cells. J Neurochem 2000;74:1478-88.
39. Tangkeangsirisin W, Serrero G. PC cell-derived growth factor. (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 2004;25:1587-92.
40. Tanaka K, Pracyk JB, Takeda K, Yu ZX, Ferrans VJ, Deshpande SS, Ozaki M, Hwang PM, Lowenstein CJ, Irani K, Finkel T. Expression of Id 1 results in apoptosis of cardiac myocytes through a redox-dependent mechanism. J Biol Chem 1998;273:25922-8.
41. Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC. Id-1 expression promotes cell survival through activation of NF-κB signaling pathway in prostatic cancer cells. Oncogene 2003;22:4498-508.
42. Wong YC, Wang X, Ling MT. Id-1 expression, and cell survival. Apoptosis 2004;9:279-89.
43. Alani RM, Young AZ, Shifflett CB. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc Natl Acad Sci USA 2001;98:7812-6.
44. INK4a Promoter hypermethylation of non-tumorous tissue adjacent to gastric cancer is correlated with glandular atrophy ana chronic inflammation. Int J Cancer 2001;93:629-34.
45. WAF1/CIP1 expression and its clinical significance in patients with early-stage gastric carcinoma. Cancer 2002;94:2107-12.
46. Kip1 protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome. J Sufg Oncol 2002;81:167-75.
47. Kadowaki Y, Ishihara S, Miyaoka Y, Rumi MA, Sato H, Kazumori H, Adachi K, Takasawa S, Okamoto H, Chiba T, Kinoshita Y. Reg protein is overexpressed in gastric cancer cells, where it activates a signal transduction pathway that converges on ERK1/2 to stimulate growth. FEBS Lett 2002;530:59-64.
48. Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M, Katano M. Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 2001;7:4136-42.
49. Schindl M, Schoppmann SF, Strobel T. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res 2003;9:779-85.
50. Ouatas T, Salerno M, Palmieri D, Steeg PS. Basic and translational advances in cancer metastasis: Nm23. J Bioenerg Biomembr 2003;35:73-9.
51. Wang YK, Ji XL, Ma NX. nm23 expression in gastric carcinoma and its relationship with lymphoproliferation. World J Gastroenterol 1999;5:87-4.
52. Han S, Guo C, Hong L, Liu J, ZheyiHan Liu C, Wang J, Wu K, Ding J, Fan D. Expression and significances of Id1 helix-loop-helix protein overexpression in gastric cancer. Cancer Lett 2004;216:63-71.